Artificial Intelligence in Medical Diagnostics Market Research Report by Technology, Service, Diagnosis Type, Diagnostic Tool, Application, End-User, Region - Global Forecast to 2027 - Cumulative Impact of COVID-19

The Global Artificial Intelligence in Medical Diagnostics Market size was estimated at USD 801.15 million in 2021 and expected to reach USD 927.42 million in 2022, and is projected to grow at a CAGR 15.93% to reach USD 1,945.62 million by 2027.

Market Statistics:
The report provides market sizing and forecast across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2018 and 2020 are considered as historical years, 2021 as the base year, 2022 as the estimated year, and years from 2023 to 2027 are considered as the forecast period.

Market Segmentation & Coverage:
This research report categorizes the Artificial Intelligence in Medical Diagnostics to forecast the revenues and analyze the trends in each of the following sub-markets:

Based on Technology, the market was studied across Computed Tomography, Magnetic Resonance Imaging, Neuroradiology, and Radiology.

Based on Service, the market was studied across Others, Tele Monitoring, and Tele-Consultation.

Based on Diagnosis Type, the market was studied across Cardiology, Neurology, and Radiology.

Based on Diagnostic Tool, the market was studied across Automated Detection System, Medical Imaging Tool, and Others.

Based on Application, the market was studied across Data Mining, Data Storage, Follow-up Plan, Image Acquisition, and Processing to Aided Reporting.

Based on End-User, the market was studied across Diagnostic Laboratory and Hospital.

Based on Region, the market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

Cumulative Impact of COVID-19:
COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.

Cumulative Impact of 2022 Russia Ukraine Conflict:
We continuously monitor and update reports on political and economic uncertainty due to the Russian invasion of Ukraine. Negative impacts are significantly foreseen globally, especially across Eastern Europe, European Union, Eastern & Central Asia, and the United States. This contention has severely affected lives and livelihoods and represents far-reaching disruptions in trade dynamics. The potential effects of ongoing war and uncertainty in Eastern Europe are expected to have an adverse impact on the world economy, with especially long-term harsh effects on Russia.This report uncovers the impact of demand & supply, pricing variants, strategic uptake of vendors, and recommendations for Artificial Intelligence in Medical Diagnostics market considering the current update on the conflict and its global response.

Competitive Strategic Window:
The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.

FPNV Positioning Matrix:
The FPNV Positioning Matrix evaluates and categorizes the vendors in the Artificial Intelligence in Medical Diagnostics Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Market Share Analysis:
The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Competitive Scenario:
The Competitive Scenario provides an outlook analysis of the various business growth strategies adopted by the vendors. The news covered in this section deliver valuable thoughts at the different stage while keeping up-to-date with the business and engage stakeholders in the economic debate. The competitive scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected help vendor to understand the gaps in the marketplace and competitor’s strength and weakness thereby, providing insights to enhance product and service.

Company Usability Profiles:
The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Artificial Intelligence in Medical Diagnostics Market, including Aidoc Medical Ltd., Arterys Inc., Butterfly Network Inc., Caption Health, Inc., Enlitic, Inc., Freenome Holdings, Inc., Gauss Surgical Inc., GE Healthcare Inc., General Vision, Inc., Google Inc., Health Fidelity, Inc., IDx Technologies Inc., Imagen Technologies, Inc., Intel Corporation, Johnson & Johnson Services, Inc., MaxQ AI, Ltd, Medtronic PLC, Microsoft Corporation, Qure.ai, Siemens Healthineers AG, SigTuple Technologies Private Limited, VUNO Inc, and Zebra Medical Vision Ltd.

The report provides insights on the following pointers:
1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:
1. What is the market size and forecast of the Global Artificial Intelligence in Medical Diagnostics Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Artificial Intelligence in Medical Diagnostics Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Artificial Intelligence in Medical Diagnostics Market?
4. What is the competitive strategic window for opportunities in the Global Artificial Intelligence in Medical Diagnostics Market?
5. What are the technology trends and regulatory frameworks in the Global Artificial Intelligence in Medical Diagnostics Market?
6. What is the market share of the leading vendors in the Global Artificial Intelligence in Medical Diagnostics Market?
7. What modes and strategic moves are considered suitable for entering the Global Artificial Intelligence in Medical Diagnostics Market?

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders

2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Rising awareness towards patient safety
5.1.1.2. Strategic alliances between healthcare facilities and AI solution providers
5.1.1.3. Growing shortage of public health workforce
5.1.2. Restraints
5.1.2.1. Limited number of AI experts
5.1.3. Opportunities
5.1.3.1. Advancements in AI and deep learning
5.1.3.2. Rise in healthcare infrastructure globally
5.1.4. Challenges
5.1.4.1. Concerns regarding data privacy
5.2. Cumulative Impact of COVID-19

6. Artificial Intelligence in Medical Diagnostics Market, by Technology
6.1. Introduction
6.2. Computed Tomography
6.3. Magnetic Resonance Imaging
6.4. Neuroradiology
6.5. Radiology

7. Artificial Intelligence in Medical Diagnostics Market, by Service
7.1. Introduction
7.2. Others
7.3. Tele Monitoring
7.4. Tele-Consultation

8. Artificial Intelligence in Medical Diagnostics Market, by Diagnosis Type
8.1. Introduction
8.2. Cardiology
8.3. Neurology
8.4. Radiology

9. Artificial Intelligence in Medical Diagnostics Market, by Diagnostic Tool
9.1. Introduction
9.2. Automated Detection System
9.3. Medical Imaging Tool
9.4. Others

10. Artificial Intelligence in Medical Diagnostics Market, by Application
10.1. Introduction
10.2. Data Mining
10.3. Data Storage
10.4. Follow-up Plan
10.5. Image Acquisition
10.6. Processing to Aided Reporting

11. Artificial Intelligence in Medical Diagnostics Market, by End-User
11.1. Introduction
11.2. Diagnostic Laboratory
11.3. Hospital

12. Americas Artificial Intelligence in Medical Diagnostics Market
12.1. Introduction
12.2. Argentina
12.3. Brazil
12.4. Canada
12.5. Mexico
12.6. United States

13. Asia-Pacific Artificial Intelligence in Medical Diagnostics Market
13.1. Introduction
13.2. Australia
13.3. China
13.4. India
13.5. Indonesia
13.6. Japan
13.7. Malaysia
13.8. Philippines
13.9. Singapore
13.10. South Korea
13.11. Taiwan
13.12. Thailand
13.13. Vietnam

14. Europe, Middle East & Africa Artificial Intelligence in Medical Diagnostics Market
14.1. Introduction
14.2. Denmark
14.3. Egypt
14.4. Finland
14.5. France
14.6. Germany
14.7. Israel
14.8. Italy
14.9. Netherlands
14.10. Nigeria
14.11. Norway
14.12. Poland
14.13. Qatar
14.14. Russia
14.15. Saudi Arabia
14.16. South Africa
14.17. Spain
14.18. Sweden
14.19. Switzerland
14.20. Turkey
14.21. United Arab Emirates
14.22. United Kingdom

15. Competitive Landscape
15.1. FPNV Positioning Matrix
15.1.1. Quadrants
15.1.2. Business Strategy
15.1.3. Product Satisfaction
15.2. Market Ranking Analysis, By Key Player
15.3. Market Share Analysis, By Key Player
15.4. Competitive Scenario
15.4.1. Merger & Acquisition
15.4.2. Agreement, Collaboration, & Partnership
15.4.3. New Product Launch & Enhancement
15.4.4. Investment & Funding
15.4.5. Award, Recognition, & Expansion

16. Company Usability Profiles
16.1. Aidoc Medical Ltd.
16.1.1. Business Overview
16.1.2. Key Executives
16.1.3. Product & Services
16.2. Arterys Inc.
16.2.1. Business Overview
16.2.2. Key Executives
16.2.3. Product & Services
16.3. Butterfly Network Inc.
16.3.1. Business Overview
16.3.2. Key Executives
16.3.3. Product & Services
16.4. Caption Health, Inc.
16.4.1. Business Overview
16.4.2. Key Executives
16.4.3. Product & Services
16.5. Enlitic, Inc.
16.5.1. Business Overview
16.5.2. Key Executives
16.5.3. Product & Services
16.6. Freenome Holdings, Inc.
16.6.1. Business Overview
16.6.2. Key Executives
16.6.3. Product & Services
16.7. Gauss Surgical Inc.
16.7.1. Business Overview
16.7.2. Key Executives
16.7.3. Product & Services
16.8. GE Healthcare Inc.
16.8.1. Business Overview
16.8.2. Key Executives
16.8.3. Product & Services
16.9. General Vision, Inc.
16.9.1. Business Overview
16.9.2. Key Executives
16.9.3. Product & Services
16.10. Google Inc.
16.10.1. Business Overview
16.10.2. Key Executives
16.10.3. Product & Services
16.11. Health Fidelity, Inc.
16.11.1. Business Overview
16.11.2. Key Executives
16.11.3. Product & Services
16.12. IDx Technologies Inc.
16.12.1. Business Overview
16.12.2. Key Executives
16.12.3. Product & Services
16.13. Imagen Technologies, Inc.
16.13.1. Business Overview
16.13.2. Key Executives
16.13.3. Product & Services
16.14. Intel Corporation
16.14.1. Business Overview
16.14.2. Key Executives
16.14.3. Product & Services
16.15. Johnson & Johnson Services, Inc.
16.15.1. Business Overview
16.15.2. Key Executives
16.15.3. Product & Services
16.16. MaxQ AI, Ltd
16.16.1. Business Overview
16.16.2. Key Executives
16.16.3. Product & Services
16.17. Medtronic PLC
16.17.1. Business Overview
16.17.2. Key Executives
16.17.3. Product & Services
16.18. Microsoft Corporation
16.18.1. Business Overview
16.18.2. Key Executives
16.18.3. Product & Services
16.19. Qure.ai
16.19.1. Business Overview
16.19.2. Key Executives
16.19.3. Product & Services
16.20. Siemens Healthineers AG
16.20.1. Business Overview
16.20.2. Key Executives
16.20.3. Product & Services
16.21. SigTuple Technologies Private Limited
16.21.1. Business Overview
16.21.2. Key Executives
16.21.3. Product & Services
16.22. VUNO Inc
16.22.1. Business Overview
16.22.2. Key Executives
16.22.3. Product & Services
16.23. Zebra Medical Vision Ltd
16.23.1. Business Overview
16.23.2. Key Executives
16.23.3. Product & Services

17. Appendix
17.1. Discussion Guide
17.2. License & Pricing